The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy of dabrafenib-trametinib combination in BRAF V600E-mutated metastatic non–small cell lung cancer: Results of the IFCT-2004 BLaDE cohort.
 
Aurélie Swalduz
Honoraria - Amgen; AZD; Boehringer Ingelheim; Roche
Consulting or Advisory Role - Amgen; AstraZeneca/MedImmune; Bristol-Myers Squibb/Medarex; Janssen; Roche
Travel, Accommodations, Expenses - Boehringer Ingelheim; Janssen
 
Michele Beau-Faller
No Relationships to Disclose
 
David Planchard
Honoraria - PeerVoice; Prime Oncology
Consulting or Advisory Role - Abbvie; AstraZeneca; BeiGene; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Daiichi Sankyo/Astra Zeneca; Janssen; MedImmune; MSD Oncology; Novartis; Pfizer; Roche; Samsung
Research Funding - Abbvie (Inst); AstraZeneca/MedImmune (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); Janssen (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Sanofi/Aventis (Inst); Taiho Pharmaceutical (Inst)
 
Julien Mazieres
Consulting or Advisory Role - AstraZeneca; Blueprint Medicines; Bristol-Myers Squibb; Hengrui Therapeutics; Lilly/ImClone; MSD; Novartis; Pfizer; Pierre Fabre; Roche/Genentech
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Pierre Fabre (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Pfizer; Roche
 
Sophie Bayle
Employment - Amgen; Roche
Honoraria - Amgen; Roche
Consulting or Advisory Role - Amgen
Research Funding - F. Hoffmann LaRoche (Inst)
 
Didier Debieuvre
Honoraria - AstraZeneca; BMS France; GlaxoSmithKline; MSD Oncology; Novartis; Pfizer; Roche
Consulting or Advisory Role - Amgen; BMS France; MSD Oncology; Novartis; OSE Immunotherapeutics; Pfizer; Sanofi/Aventis
Research Funding - AstraZeneca (Inst); Bayer (Inst); BMS france (Inst); Boehringer Ingelheim (Inst); Chiesi (Inst); Chugai Pharma (Inst); GlaxoSmithKline (Inst); Janssen (Inst); Lilly (Inst); MSD Oncology (Inst); Novartis (Inst); OSE Immunotherapeutics (Inst); Pfizer (Inst); Roche (Inst); Sanofi (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - AstraZeneca; BMS france; BMS France; BMS france; Boehringer Ingelheim; Boehringer Ingelheim France; Lilly (Inst); MSD Oncology; MSD Oncology (Inst); Novartis; novartis France; Pfizer; Roche; Roche; Takeda
 
Vincent Fallet
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Janssen Oncology; Pfizer; Roche; Takeda
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; Takeda
 
Margaux Geier
Consulting or Advisory Role - Chugai Pharma; Pfizer; Sanofi
 
Alexis B Cortot
Honoraria - AstraZeneca; Bristol-Myers Squibb; MSD Oncology; Novartis; Pfizer; Pfizer; Roche; Takeda
Consulting or Advisory Role - AstraZeneca; Janssen; Novartis; Pfizer; Roche; Takeda
Research Funding - Merck Serono (Inst); Novartis (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Novartis; Pfizer; Roche
 
Sebastien Couraud
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Chugai Pharma; Laidet Medical; Lilly; Merck Serono; MSD; Novartis; Novartis; Roche
Research Funding - Amgen (Inst); AstraZeneca (Inst); Sysmex (Inst)
Expert Testimony - Roche
Travel, Accommodations, Expenses - AstraZeneca; Boehringer Ingelheim; Chugai Pharma; Laidet Medical; Pfizer; Roche; VitalAire
Other Relationship - Inovotion
 
Catherine Daniel
No Relationships to Disclose
 
Eric Pichon
Honoraria - AstraZeneca; Bristol-Myers Squibb; Takeda
 
Pascale Missy
No Relationships to Disclose
 
Franck Morin
No Relationships to Disclose
 
Virginie Westeel
Consulting or Advisory Role - AstraZeneca; Bristol Myers Squibb; MSD Oncology; Roche; Takeda
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; Roche
Research Funding - Abbvie (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Lilly (Inst); Merck Serono (Inst); MSD Oncology (Inst); Novartis (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bristol Myers Squibb; MSD Oncology
 
Jean-Bernard Auliac
No Relationships to Disclose
 
Remi Veillon
No Relationships to Disclose